Molnupiravir and nirmatrelvir-ritonavir reduce COVID-19 mortality in hospitalized patients
1. In this trial emulation study, molnupiravir and nirmatrelvir-ritonavir reduced all-cause mortality in vaccinated and unvaccinated hospitalized patients with coronavirus ...